The AI Revolution in Drug Development: How Key Innovators are Transforming the Industry
The landscape of drug development is undergoing a monumental transformation, driven by the integration of artificial intelligence (AI)...
top of page
matttongs
Jul 293 min read
Venture Capital in Biopharma
Role of Intelisci in Ensuring Due Diligence and Active Involvement in portfolio newcos. While the biopharma sector experienced a...
matttongs
Jul 292 min read
Venture Capital Investment in Biopharma Post-COVID
High Point After COVID In 2021, venture capital (VC) investment in biopharma reached an all-time high, driven by the surge in demand for...
matttongs
Jul 292 min read
Venture Capital in Biopharma - Risk mitigation.
Venture capital (VC) companies employ several strategies to mitigate or "derisk" their investments, particularly in high-risk sectors...
matttongs
Jul 292 min read
Venture Capital in Biopharma
Venture capital (VC) in the biopharma sector involves investing in early-stage pharmaceutical and biotechnology companies with the...
matttongs
Oct 18, 20232 min read
Advisory Insights for Biotech Leaders in Transition: A Look at Fierce Bio's October Trackers
The biotech landscape, as reflected in Fierce Bio's layoff and funding trackers for October, presents a duality. While some companies are...
matttongs
Jun 15, 20233 min read
Risky Rewards: How Biotech Firms Leverage Equity for Executive Edge
As competition for top talent continues to intensify in the field of immune-mediated drug development, both large pharmaceutical...
matttongs
Jun 15, 20232 min read
Leadership in the Crucible: Navigating the Search for Executives in Immune-Mediated Drug Development
Finding executive talent, such as C-suite and Vice President (VP) level roles, for the field of immune-mediated drug development adds an...
matttongs
Jun 15, 20232 min read
Navigating the Talent Landscape in Immune-Mediated Drug Development
The field of immune-mediated drug development is a highly competitive and specialized one, requiring skilled professionals across various...
matttongs
Jun 15, 20232 min read
Unleashing the Power of the Immune System: Triumphs and Trials in Immune-Mediated Drug Development
The human immune system is incredibly complex, involving numerous cell types, signaling pathways, and molecular mechanisms. As our...
matttongs
Jun 15, 20232 min read
The Evolution of Immune-Mediated Drug Development: A Journey Through Time
Immunology, the science of the body's defense mechanism, has been a field of study for centuries. However, the advent of immune-mediated...
matttongs
May 24, 20232 min read
🌟 AI. Part 5: Nurturing the AI-Ready Workforce:
Skills Evolution and Talent Acquisition Challenges ⚙️👩💼 As AI continues to reshape the landscape of drug development, it is crucial to...
matttongs
May 24, 20232 min read
⚡ AI. Part 4: Overcoming Challenges: Navigating the Path of AI in Drug Development ⚠️🚧
As we embrace the potential of AI in drug development, it is crucial to address the challenges that lie ahead. Let's delve into key...
matttongs
May 24, 20232 min read
💼 AI. Part 3: Funding the Future:
Uncover emerging funding options tailor-made for startups developing AI-driven approaches. From venture capital to strategic...
matttongs
May 24, 20232 min read
🚀 AI. Part 2: Modalities & Indications:
A focus on the modalities poised to benefit most from AI, from small molecules to gene therapies. Thoughts on how AI is reshaping the...
matttongs
May 24, 20232 min read
🔍 AI - Part 1: Unleashing Efficiency
Explore how AI revolutionizes molecule identification, virtual screening, and clinical trial optimization. Discover how pioneering...
matttongs
May 20, 20232 min read
It helps to have true experience in the room.
When thinking about the limitations of traditional executive search firms that operate in the field of Cell & Gene Therapy, I concluded...
matttongs
May 9, 20232 min read
A summary of evolving approaches to AAV improving regional selection in the Brain.
"The ability to engineer AAV capsids with improved transduction efficiency, specificity, and tropism for particular cell types or brain...
matttongs
Apr 17, 20232 min read
Breakthrough in Parkinson's
A new Biomarker can identify the Disease before onset, and may lead to a simple test. Fantastic news for Patents and Researchers. What...
matttongs
Mar 29, 20232 min read
SVB's fall is a blow for biotech, but Life (sciences) will find a way!
As an executive search consultant supporting biotech, I have been following the potential impact of Silicon Valley Bank's (SVB) collapse...
bottom of page